Alpha Cognition (NASDAQ:ACOG) Lowered to "Sell" Rating by Wall Street Zen

Key Points

• Alpha Cognition (NASDAQ:ACOG) was downgraded from a "hold" to a "sell" rating by Wall Street Zen, reflecting concerns over its stock performance.
• The company's recent quarterly earnings report revealed an EPS of ($0.65), missing the consensus estimate significantly, with actual revenue also falling short of expectations.
• Insider transactions showed a director selling 27,778 shares at $9.00 each, leading to a significant decrease in their position, while another director increased their ownership by purchasing 15,000 shares at $8.49.

Alpha Cognition (NASDAQ:ACOG - Get Free Report) was downgraded by stock analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a report issued on Saturday.

Alpha Cognition Stock Performance

Alpha Cognition stock opened at $6.80 on Friday. The company has a 50-day simple moving average of $8.14 and a 200-day simple moving average of $8.11. The firm has a market capitalization of $142.13 million, a P/E ratio of -4.25 and a beta of 2.63. Alpha Cognition has a one year low of $3.75 and a one year high of $11.54.

Alpha Cognition (NASDAQ:ACOG - Get Free Report) last released its quarterly earnings results on Thursday, August 14th. The company reported ($0.65) EPS for the quarter, missing the consensus estimate of ($0.46) by ($0.19). The firm had revenue of $1.66 million for the quarter, compared to analyst estimates of $2.32 million.

Insider Transactions at Alpha Cognition

In related news, Director Phillip Joseph Mertz sold 27,778 shares of the stock in a transaction dated Monday, August 18th. The shares were sold at an average price of $9.00, for a total value of $250,002.00. Following the completion of the transaction, the director owned 22,462 shares in the company, valued at $202,158. This represents a 55.29% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this hyperlink. Also, Director Robert James Wills bought 15,000 shares of the firm's stock in a transaction that occurred on Monday, August 18th. The stock was bought at an average price of $8.49 per share, with a total value of $127,350.00. Following the transaction, the director directly owned 15,000 shares in the company, valued at $127,350. This represents a ∞ increase in their ownership of the stock. The disclosure for this purchase can be found here. Corporate insiders own 14.00% of the company's stock.

Hedge Funds Weigh In On Alpha Cognition

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. AWM Investment Company Inc. bought a new position in Alpha Cognition in the 1st quarter valued at about $5,785,000. Cable Car Capital LP grew its position in Alpha Cognition by 68.8% in the 2nd quarter. Cable Car Capital LP now owns 869,002 shares of the company's stock valued at $8,108,000 after buying an additional 354,278 shares in the last quarter. Manatuck Hill Partners LLC grew its position in Alpha Cognition by 74.6% in the 2nd quarter. Manatuck Hill Partners LLC now owns 117,000 shares of the company's stock valued at $1,092,000 after buying an additional 50,000 shares in the last quarter. Villere ST Denis J & Co. LLC grew its position in Alpha Cognition by 201.0% in the 1st quarter. Villere ST Denis J & Co. LLC now owns 71,778 shares of the company's stock valued at $363,000 after buying an additional 47,928 shares in the last quarter. Finally, Marshall Wace LLP acquired a new stake in Alpha Cognition in the 2nd quarter valued at about $600,000.

About Alpha Cognition

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.